SCAI THERAPEUTICS

PharmaceuticalsSeries CDaejeon, South Koreascaitrx.com

Latest round

Series C

Last raised

Jul 2026

Total raised

$39M

Investors

11

About SCAI THERAPEUTICS

Based in Seoul, South Korea and founded in 2019, SCAI THERAPEUTICS is a company that develops pharmaceutical technology to increase the bioavailability of drugs. Bioavailability refers to the effect that a certain amount of a drug exerts in the body. Drugs show different efficacy depending on various factors such as crystalline form, purity, and formulation form. The company operates a drug delivery platform technology, MOASIS. Molecularly Associated Innovative Substance (MOASIS) enables the construction of novel molecular clusters from small molecules within critical length scales.

Who invested in SCAI THERAPEUTICS

11 investors across 3 rounds

See all investors in SCAI THERAPEUTICS

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jul 10, 2026

    Amount

    $8.6M

    Investors

    Locked

  2. Series B

    Jul 14, 2021

    Amount

    $28M

    Investors

    Locked

  3. Series A

    Sep 1, 2019

    Amount

    $2.5M

    Investors

    Locked

Questions about SCAI THERAPEUTICS

Who invested in SCAI THERAPEUTICS?

SCAI THERAPEUTICS has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SCAI THERAPEUTICS raised?

SCAI THERAPEUTICS has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did SCAI THERAPEUTICS last raise money?

SCAI THERAPEUTICS's most recent round on record is a Series C, in Jul 2026.

What does SCAI THERAPEUTICS do?

Based in Seoul, South Korea and founded in 2019, SCAI THERAPEUTICS is a company that develops pharmaceutical technology to increase the bioavailability of drugs.

Where is SCAI THERAPEUTICS headquartered?

SCAI THERAPEUTICS is headquartered in Daejeon, South Korea.

Which VCs invest in companies like SCAI THERAPEUTICS?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at SCAI THERAPEUTICS's stage. Their profiles are linked below.

Raising like SCAI THERAPEUTICS? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.